Literature DB >> 27792719

[Comparative study of the efficacy of larva therapy for debridement and control of bacterial burden compared to surgical debridement and topical application of an antimicrobial].

José Contreras-Ruiz1, Adán Fuentes-Suárez1, Sara Arroyo-Escalante2, David Moncada-Barron2, María Cristina Sosa-de-Martínez3, Ernesto Maravilla-Franco4, Judith Guadalupe Domínguez-Cherit5.   

Abstract

Maggot debridement therapy (MDT) is the use of medical grade maggots of the fly Lucilia sericata for wound debridement. Recent observations show that MDT decreases bacterial burden as well. Venous ulcers are the most commonly seen in wound clinics and require, besides adequate treatment of venous hypertension, proper wound bed preparation with debri dement of necrotic tissue and control of potential infections. To evaluate the efficacy of MDT in venous ulcers a randomized controlled trial was designed to compare MDT to surgical debridement and topical application of silver sulfadiazine (SSD) in 19 patients for 4 weeks. The study variables were area reduction, wound bed characteristics, pain, odor, anxiety and bacterial burden using quantitative tissue biopsies. MDT was effective as surgical debridement associated with topical SDD in the debridement of the wound and in reducing its size. A significant difference was observed in the reduction of bacterial burden in favor of the MDT group. Odor and anxiety increased in the MDT group without any difference in the pain intensity between groups. In conclusion, this study suggests that MDT is as effective as surgical debridement for the debridement of necrotic tissue and promote wound healing in venous ulcers and better at reducing bacterial burden.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27792719

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  2 in total

1.  Clinical study of Maggot therapy for Fournier's gangrene.

Authors:  Alicia Fonseca-Muñoz; Hugo E Sarmiento-Jiménez; Rafael Pérez-Pacheco; Patricia J Thyssen; Ronald A Sherman
Journal:  Int Wound J       Date:  2020-07-21       Impact factor: 3.315

2.  Use of maggot debridement therapy in hospitalised patients in Germany.

Authors:  Olga von Beckerath; Susanne Kanya; Gabor Gäbel; Knut Kröger; Benjamin Juntermanns
Journal:  Int Wound J       Date:  2019-11-03       Impact factor: 3.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.